Latest news
Australian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatchBiotechDispatch · Mon, 10 Aug 2026 08:35:18 GMTAdAlta Reports All Five Remaining EW-001 Mesothelioma Patients Still Alive at July 2026 Update - KalkineKalkine · Mon, 10 Aug 2026 02:34:07 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.netMesothelioma.net · Wed, 05 Aug 2026 15:29:01 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTAdAlta Reports Two-Year Survival Milestone for First EW-001 Complete Responder in Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMTAdAlta (ASX:1AD) Reports Two-Year Cancer-Free Survival Milestone in EW-001 Mesothelioma Study - KalkineKalkine · Wed, 05 Aug 2026 00:17:00 GMT